Radiation dermatitis: current view on pathogenesis, principles of profilaxis and treatment-Reference-Cited by-同舟云学术

Radiation dermatitis: current view on pathogenesis, principles of profilaxis and treatment

Published:2023-02-03 Issue:4 Volume:9 Page:81-87
ISSN:2413-5496
Container-title:Russian Journal of Pediatric Hematology and Oncology
language:
Short-container-title:Ross. ž. det. gematol. onkol.

Author:

Belysheva T. S.¹^ORCID,Valiev T. T.¹^ORCID,Shatokhina E. A.²^ORCID,Grigorenko V. A.¹^ORCID,Polonskaya A. S.³^ORCID,Kirgizov K. I.¹^ORCID,Varfolomeeva S. R.¹^ORCID

Affiliation:

1. N. N. Blokhin National Medical Research Centre of Oncology, Ministry of Health of Russia

2. Central State Medical Academy Department for Presidential Affairs of the Russian Federation; Medical Research and Educational Center at the Lomonosov Moscow State University

3. Central State Medical Academy Department for Presidential Affairs of the Russian Federation

Abstract

Radiation therapy (RT) is associated with high incidence of dermatologic adverse events. Radiation dermatitis is a major cutaneous side effect of RT. The article presents current views on pathogenesis of radiation dermatitis and modern approaches to prophylaxis and treatment of this cutaneous reaction.

Publisher

OOO Grafika

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference40 articles.

1. Lacouture M. E. Dermatologic principles and practice in oncology: conditions of the skin, hair, and nails in cancer patients. John Wiley & Sons, 2014.

2. Salvo N., Barnes E., van Draanen J., Stacey E., Mitera G., Breen D., Giotis A., Czarnota G., Pang J., De Angelis C. Prophylaxis and management of acute radiation-induced skin reactions: a systematic review of the literature. Curr Oncol. 2010; 17 (4): 94–112. doi: 10.3747/co.v17i4.493.

3. Janko M., Ontiveros F., Fitzgerald T. J., Deng A., DeCicco M., Rock K. L. IL-1 generated subsequent to radiation-induced tissue injury contributes to the pathogenesis of radiodermatitis. Radiat Res. 2012; 178 (3): 166–72. doi: 10.1667/rr3097.1.

4. Lamkanfi M. Emerging inflammasome effector mechanisms. Nat Rev Immunol. 2011; 11 (3): 213–20. doi: 10.1038/nri2936.

5. Allam R., Lawlor K. E., Yu E. C. Mitochondrial apoptosis is dispensable for NLRP3 infl ammasome activation but non-apoptotic caspase-8 is required for infl ammasome priming. EMBO Rep. 2014; 15 (9): 982–90. doi: 10.15252/embr.201438463.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Possibilities of remedial treatment of dermatological adverse events associated with cancer treatment using physical factors;Fizioterapevt (Physiotherapist);2023-06-02